I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Conkling, Paul
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (25)
OpenAccess-fulltext (18)
Sorted by: Relevance
Sorted by: Year
?
1
Clinical Activity and Safety of Atezolizumab in a Phase 1 S..:
Chiang, Anne C.
;
Sequist, Lecia Van Dam
;
Gilbert, Jill
...
Clinical Lung Cancer. 21 (2020) 5 - p. 455-463.e4 , 2020
Link:
https://doi.org/10.1016/..
?
2
Atezolizumab in patients with advanced non-small cell lung ..:
Gadgeel, Shirish M.
;
Lukas, Rimas V.
;
Goldschmidt, Jerome
...
Lung Cancer. 128 (2019) - p. 105-112 , 2019
Link:
https://doi.org/10.1016/..
?
3
Extended dosing with CC‐486 (oral azacitidine) in patients ..:
Savona, Michael R.
;
Kolibaba, Kathryn
;
Conkling, Paul
...
American Journal of Hematology. 93 (2018) 10 - p. 1199-1206 , 2018
Link:
https://doi.org/10.1002/..
?
4
P1.07-002 G1T28, a Cyclin Dependent Kinase 4/6 Inhibitor, i..:
Hart, Lowell
;
Roberts, Patrick
;
Ferrarotto, Renata
...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S696 , 2017
Link:
https://doi.org/10.1016/..
?
5
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:
Boccia, Ralph V.
;
Bessudo, Alberto
;
Agajanian, Richy
...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 7 - p. 433-437 , 2017
Link:
https://doi.org/10.1016/..
?
6
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, C..:
Boccia, Ralph
;
Bessudo, Alberto
;
Agajanian, Richy
...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e14 , 2017
Link:
https://doi.org/10.1016/..
?
7
A phase I dose-escalation study of MEDI-575, a PDGFRα monoc..:
Becerra, Carlos R.
;
Conkling, Paul
;
Vogelzang, Nicholas
...
Cancer Chemotherapy and Pharmacology. 74 (2014) 5 - p. 917-925 , 2014
Link:
https://doi.org/10.1007/..
?
8
Antitumor activity and safety of combination therapy with t..:
Smith, David A.
;
Conkling, Paul
;
Richards, Donald A.
...
Cancer Immunology, Immunotherapy. 63 (2014) 8 - p. 787-796 , 2014
Link:
https://doi.org/10.1007/..
?
9
A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizu..:
Uronis, Hope E.
;
Bendell, Johanna C.
;
Altomare, Ivy
...
The Oncologist. 18 (2013) 3 - p. 271-272 , 2013
Link:
https://doi.org/10.1634/..
?
10
Phase 1b study results of IMO-2055, a novel TLR9 agonist, i..:
Smith, David A.
;
Conkling, Paul
;
Richards, Donald A.
...
Lung Cancer. 77 (2012) - p. S39 , 2012
Link:
https://doi.org/10.1016/..
?
11
A phase I study of imexon plus gemcitabine as first-line th..:
Cohen, Steven J.
;
Zalupski, Mark M.
;
Modiano, Manuel R.
...
Cancer Chemotherapy and Pharmacology. 66 (2009) 2 - p. 287-294 , 2009
Link:
https://doi.org/10.1007/..
?
12
Results of a Phase II study of weekly docetaxel and carbopl..:
Weissman, Charles H.
;
Sandbach, John
;
Brooker, Reginald
...
Lung Cancer. 52 (2006) 3 - p. 313-317 , 2006
Link:
https://doi.org/10.1016/..
?
13
Effect of diethyldithiocarbamate (DDC) on human monocyte fu..:
Conkling, Paul
;
Cornwell, David G.
;
Sagone Jr., Arthur L.
Inflammation. 9 (1985) 2 - p. 149-161 , 1985
Link:
https://doi.org/10.1007/..
?
14
Real-World Outcomes of Trilaciclib Among Patients with Exte..:
Goldschmidt, Jerome
;
Hart, Lowell
;
Scott, Jeffrey
...
Advances in Therapy. 40 (2023) 10 - p. 4189-4215 , 2023
Link:
https://doi.org/10.1007/..
?
15
Trilaciclib Use and Chemotherapy-Induced Myelosuppression A..:
Goldschmidt, Jerome
;
Monnette, Alisha
;
Shi, Ping
...
International Journal of Cancer Care and Delivery. 2 (2022) Supplement 2 - p. , 2022
Link:
https://doi.org/10.53876..
1-15